Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma

Statistics notes: Multiple significance tests: the Bonferroni method

1995 • 3,474 citations

Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

2001 • 2,658 citations

Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials

1997 • 2,491 citations

Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases

2006 • 2,100 citations

Metastatic pattern of malignant melanoma

1978 • 630 citations

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma

1998 • 548 citations

Determinants of Outcome in Melanoma Patients With Cerebral Metastases

2004 • 431 citations

Current Management of Brain Metastases, With a Focus on Systemic Options

2005 • 364 citations

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival

1998 • 265 citations

Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features

2008 • 213 citations

Patterned distribution of metastases from malignant melanoma in humans.

1983 • 193 citations

Determinants of survival in patients with brain metastases from cutaneous melanoma

2010 • 158 citations

Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery

2002 • 137 citations

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)

2009 • 133 citations

Surgery and radiotherapy in the treatment of cutaneous melanoma

2009 • 129 citations

Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors.

1997 • 125 citations

Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma. Radiation therapy oncology group brain metastases study I and II

1980 • 123 citations

Gamma Knife Radiosurgery for Malignant Melanoma Brain Metastases

2006 • 118 citations

Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma

2002 • 117 citations

Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694

2008 • 109 citations

Prolonged survival of 2 years or longer for patients with disseminated melanoma

1997 • 109 citations

The treatment of brain metastases from malignant melanoma

2002 • 94 citations

Radiosurgery without whole brain radiotherapy in melanoma brain metastases

1998 • 86 citations

Intracranial metastases from melanoma clinical features and treatment by accelerated fractionation

1985 • 83 citations

Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases

2006 • 69 citations

A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma

2004 • 64 citations

Treatment of Brain Metastases From Melanoma

2003 • 44 citations

Long-Term Survival Analysis in Metastatic Melanoma: Serum S100B Is an Independent Prognostic Marker and Superior to LDH

2008 • 41 citations

Treatment Options for Limited or Symptomatic Metastatic Melanoma

2008 • 36 citations

Selection of Patients With Melanoma Brain Metastases for Aggressive Treatment

2003 • 34 citations